<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Santo for Hall&#187; Type</title>
	<atom:link href="http://www.santoforhall.com/tag/type/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.santoforhall.com</link>
	<description>A tribute to and petition for Ron Santo to be inducted in the Major League Baseball Hall of Fame</description>
	<lastBuildDate>Thu, 09 Feb 2012 22:01:37 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Curing Diabetes: Type 2 As an accepted way of life was &#8211; The Atlantic</title>
		<link>http://www.santoforhall.com/2012/02/08/curing-diabetes-type-2-as-an-accepted-way-of-life-was-the-atlantic/</link>
		<comments>http://www.santoforhall.com/2012/02/08/curing-diabetes-type-2-as-an-accepted-way-of-life-was-the-atlantic/#comments</comments>
		<pubDate>Wed, 08 Feb 2012 14:01:16 +0000</pubDate>
		<dc:creator>Scott Lewis</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[accepted]]></category>
		<category><![CDATA[Atlantic]]></category>
		<category><![CDATA[Curing]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Life]]></category>
		<category><![CDATA[Type]]></category>

		<guid isPermaLink="false">http://www.santoforhall.com/2012/02/08/curing-diabetes-type-2-as-an-accepted-way-of-life-was-the-atlantic/</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;">
<td width="80" align="center" valign="top" <font style = "font-size: 85%; font-family: Arial, sans-serif"> <a href = "http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNGIVJOTOu7GRPnGCXD1qM-nW0DLrw&amp;url=http://www.inloughborough.com/news/100680/Universities%2520of%2520Leicester%2520and%2520Cambridge%2520spearhead%2520one%2520of%2520UKs%2520biggest%2520diabetes%2520prevention%2520programmes" alt = " "border =" 1 "width =" 80 "height =" 80 "/> <br /> <font size = "-2"> Loughborough News </font> </a> </font> </td>
<td valign = "top" class = "j"> style = <font "font-size: 85%; font-family: Arial, sans-serif "> <br /> 
<div style = "padding-top: 0.8em "> <img alt="" height="1" width="1" /> </div>
<p> class=&#8221;lh&#8221;> <a <b> diabetes </b>: As a recognized Type 2 Lifestyle Became </b> </a> <br /> <font size="-1" color="#6f6f6f"> The Atlantic </font> </b> </font> <br /> <font size="-1"> By John-Manuel Andriote <b> diabetes </b> is a big business, and many were convinced that the management there is always their only option. But it is possible to cure the disease. Chuck Lynch, I thought that after he and type 2 (adult onset) diabetes diagnosed <b> </b>, <b> &#8230; </B> </font> <br /> <font size="-1"> <a of Leicester and Cambridge <b> spearhead one of the UK&#8217;s largest <b> diabetes </b> &#8230; </B> </a> <font size="-1" color="#6f6f6f"> <nobr> Loughborough News </nobr> </font> </font> <br /> <font size = "- 1 "> <a $  3,000,000 grant to receive <b> diabetes </b> education </a> <font size="-1" color="#6f6f6f"> <nobr> red and black </nobr> </font> / <verbessern font> <br /> <font size="-1" class="p"> </font> <br /> <font size="-1"> class = &#8220;p&#8221; <a class = "p" href = "http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNHQn-VGnSC74DbbtdxxTdMe03l-sg&amp;url=http://www.theatlantic.com/health/archive/2012/02/curing-diabetes-how-type-2-became-an-accepted-lifestyle/252598/"> <nobr> <b> all 4 news articles »</b> </nobr> </a> </font> </div>
<p> </font> </td>
</tr>
</table>
<p><A rel = "nofollow" - Google News </a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.santoforhall.com/2012/02/08/curing-diabetes-type-2-as-an-accepted-way-of-life-was-the-atlantic/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Type 2 diabetes therapy on new ACP guideline &#8211; Medscape</title>
		<link>http://www.santoforhall.com/2012/02/07/type-2-diabetes-therapy-on-new-acp-guideline-medscape/</link>
		<comments>http://www.santoforhall.com/2012/02/07/type-2-diabetes-therapy-on-new-acp-guideline-medscape/#comments</comments>
		<pubDate>Tue, 07 Feb 2012 02:00:50 +0000</pubDate>
		<dc:creator>Scott Lewis</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[guideline]]></category>
		<category><![CDATA[Medscape]]></category>
		<category><![CDATA[Therapy]]></category>
		<category><![CDATA[Type]]></category>

		<guid isPermaLink="false">http://www.santoforhall.com/2012/02/07/type-2-diabetes-therapy-on-new-acp-guideline-medscape/</guid>
		<description><![CDATA[Medscape 6th February 2012 &#8211; Metformin should be the first drug for most patients with type 2 diabetes have added refractory to lifestyle changes, with a second drug if necessary, according to a new clinical practice guideline from the American College of &#8230;]]></description>
			<content:encoded><![CDATA[<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;">
<td width="80" align="center" valign="top" <font style = "font-size: 85%; font-family: Arial, sans-serif"> </font> </td>
<td valign="top" class="j"> <font style = "font-size: 85 % font-family: Arial, sans-serif "> <br /> 
<div style="padding-top:0.8em;"> <img old =" "height =" a "width =" 1" /> </div>
<p> class=&#8221;lh&#8221;> <a 2 <B> diabetes </b> therapy on new ACP guideline </b> </a> <br /> <font size="-1"> <b> color=&#8221;#6f6f6f&#8221;> Medscape </font> </b> </font> <br /> <font size="-1"> 6th February 2012 &#8211; Metformin should be the first drug for most patients with type 2 diabetes have </b> added refractory to lifestyle changes, with a second drug if necessary, according to a new clinical practice guideline from the American College of <b> &#8230; </B> </font> <br /> <font size = "-1"> <a preferred drug for type 2 diabetes </b>, experts say </a> <font size = " -1 "color =" # 6f6f6f "> <nobr> U.S. News &#038; World Report </nobr> </font> </font> <br /> <font size="-1"> <a guideline: metformin best HbA1c control </a> <font size="-1" color="#6f6f6f"> MedPage Today <nobr> </nobr> </font> </font> <br /> <font size = "-1 "> <a Drug treatment of type 2 diabetes </b> Mellitus: Clinical Practice Guideline <b> &#8230; </B> </a> <font size="-1" color="#6f6f6f"> <nobr> Annals of Internal Medicine </nobr> </font> </font> <br /> <font size = "-1" class = "p"> <a Xpress </nobr> </a> &#8211; <a today </nobr> </a> </font> <br /> <font size="-1"> class = &#8220;p&#8221; class = <a "p" "http://news.google.com href = / news / mehr? ncl = ned = en &#038; dhQPTj9Ecfo_5nMAEeH9Ci7DcWiTM "> <nobr> <b> all 13 news articles »</b> </nobr> </a> </font> </div>
<p> </font> </td>
</tr>
</table>
<p><A rel = "nofollow" - Google News </a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.santoforhall.com/2012/02/07/type-2-diabetes-therapy-on-new-acp-guideline-medscape/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fundraiser for Bayville boy with type 1 diabetes Planned &#8211; Patch.com</title>
		<link>http://www.santoforhall.com/2012/02/04/fundraiser-for-bayville-boy-with-type-1-diabetes-planned-patch-com/</link>
		<comments>http://www.santoforhall.com/2012/02/04/fundraiser-for-bayville-boy-with-type-1-diabetes-planned-patch-com/#comments</comments>
		<pubDate>Sat, 04 Feb 2012 19:06:20 +0000</pubDate>
		<dc:creator>Scott Lewis</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bayville]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[fundraiser]]></category>
		<category><![CDATA[Patch.com]]></category>
		<category><![CDATA[planned]]></category>
		<category><![CDATA[Type]]></category>

		<guid isPermaLink="false">http://www.santoforhall.com/2012/02/04/fundraiser-for-bayville-boy-with-type-1-diabetes-planned-patch-com/</guid>
		<description><![CDATA[patch. com By Catherine Galioto and Patricia A. Miller, a local boy working families in order to increase its support to its type 1 administration diabetes , by adding an &#8220; diabetes Dog Awareness&#8221; of the family. A series of local fundraisers will help the money &#8230; and more »]]></description>
			<content:encoded><![CDATA[<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;">
<td width="80" align="center" valign="top" <font style = "font-size: 85%; font-family: Arial, sans-serif"> </font> </td>
<td valign="top" class="j"> <font style = "font-size: 85 % font-family: Arial, sans-serif "> <br /> 
<div style="padding-top:0.8em;"> <img old =" "height =" a "width =" 1" /> </div>
<p> class=&#8221;lh&#8221;> <a for Bayville boy with type 1 diabetes </b> plans </b> </a> <br /> <font size="-1"> <b> color=&#8221;#6f6f6f&#8221;> patch. com </font> </b> </font> <br /> <font size="-1"> By Catherine Galioto and Patricia A. Miller, a local boy working families in order to increase its support to its type 1 administration <b> diabetes </b>, by adding an &#8220;<b> diabetes </b> Dog Awareness&#8221; of the family. A series of local fundraisers will help the money <b> &#8230; </B> </font> <br /> <font size="-1" class="p"> </font> <br /> <font size="-1"> <a class = "p" class = "p" href = "http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNH-0IqY0JdKaTyirsysENx3zpqwqA&amp;url=http://berkeley-nj.patch.com/articles/deven"> <nobr> <b> and more »</b> </nobr> </a> </font> </div>
<p> </font> </td>
</tr>
</table>
<p><A rel = "nofollow" - Google News </a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.santoforhall.com/2012/02/04/fundraiser-for-bayville-boy-with-type-1-diabetes-planned-patch-com/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Approves Once-A-Day Drug for Type 2 Diabetes &#8211; Medscape</title>
		<link>http://www.santoforhall.com/2012/02/04/fda-approves-once-a-day-drug-for-type-2-diabetes-medscape/</link>
		<comments>http://www.santoforhall.com/2012/02/04/fda-approves-once-a-day-drug-for-type-2-diabetes-medscape/#comments</comments>
		<pubDate>Sat, 04 Feb 2012 07:38:25 +0000</pubDate>
		<dc:creator>Scott Lewis</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[approves]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[drug]]></category>
		<category><![CDATA[Medscape]]></category>
		<category><![CDATA[OnceADay]]></category>
		<category><![CDATA[Type]]></category>

		<guid isPermaLink="false">http://www.santoforhall.com/2012/02/04/fda-approves-once-a-day-drug-for-type-2-diabetes-medscape/</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[<table border="0" cellhttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060adding="2" cellshttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060acing="7" style="vertical-align:tohttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060;">
<td width="80" align="center" valign="tohttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060" <font style = "font-size: 85%; font-family: Arial, sans-serif"> </font> </td>
<td valign="tohttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060" class="j"> <font style = "font-size: 85 % font-family: Arial, sans-serif "> <br /> 
<div style="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060adding-tohttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060:0.8em;"> <img old =" "height =" a "width =" 1" /> </div>
<p> class=&#8221;lh&#8221;> <a Ahttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060roves Once-A-Day Drug for Tyhttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060e 2 Diabetes </b> </b> </a> <br /> <font size = "-1 "> color = <b> <font "# 6f6f6f"> Medscahttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060e </font> </b> </font> <br /> <font size="-1"> third February 2012 &#8211; Merck announced on 2 Ahttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060roved February that the U.S. Food and Drug Administration (FDA) sitaglihttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060tin and metformin hydrochloride (HCl) was-release tablets (Janumet XR) for treatment of tyhttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060e 2 diabetes </b>. </Font> <br /> <font size="-1"> <a ahttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060roved Merck's new tyhttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060e 2 diabetes </b> Drug Janumet </a> <font size = "-1" color = "# 6f6f6f "> <nobr> a sweet life </nobr> </font> </font> <br /> <font size="-1"> <a Okays Merck's Janumet XR for Tyhttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060e 2 Diabetes </b > &#8211; Uhttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060date </a> <font size="-1" color="#6f6f6f"> <nobr> RTT News </nobr> </font> </font> <br /> <font size = "-1 "> <a ahttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060roved Janumet (R) XR (sitaglihttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060tin and metformin HCl sustained-<b> <... / b> </a> <font size="-1" color="#6f6f6f"> <nobr> MarketWatch (http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060ress release) </nobr> </font> </font> <br /> <font size="-1" class="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060"> <a /> <font size="-1"> class = &#8220;http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060 &#8220;class = <a href = "http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060" "htthttp://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEn8-6ucCxodbSGT-6GFZP7XQGxRQ&amp;url=http://www.medscape.com/viewarticle/758060://news.google.com/news/more?ncl=d_fz5XSYf-HPaTMwHivCQWMf7sVxM&#038;ned=us"> <nobr> <b> all 40 news articles» </b> </nobr> </a> </font> </div>
<p> </font> </td>
</tr>
</table>
<p><A rel = "nofollow" - Google News </a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.santoforhall.com/2012/02/04/fda-approves-once-a-day-drug-for-type-2-diabetes-medscape/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The weight loss is the key in the fight against type 2 diabetes &#8211; San Francisco Chronicle</title>
		<link>http://www.santoforhall.com/2012/02/04/the-weight-loss-is-the-key-in-the-fight-against-type-2-diabetes-san-francisco-chronicle/</link>
		<comments>http://www.santoforhall.com/2012/02/04/the-weight-loss-is-the-key-in-the-fight-against-type-2-diabetes-san-francisco-chronicle/#comments</comments>
		<pubDate>Sat, 04 Feb 2012 02:00:09 +0000</pubDate>
		<dc:creator>Scott Lewis</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Against]]></category>
		<category><![CDATA[Chronicle]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[fight]]></category>
		<category><![CDATA[Francisco]]></category>
		<category><![CDATA[Loss]]></category>
		<category><![CDATA[Type]]></category>
		<category><![CDATA[Weight]]></category>

		<guid isPermaLink="false">http://www.santoforhall.com/2012/02/04/the-weight-loss-is-the-key-in-the-fight-against-type-2-diabetes-san-francisco-chronicle/</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;">
<td width="80" align="center" valign="top" <font style = "font-size: 85%; font-family: Arial, sans-serif"> <a href = "http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNGk2qg-0C2XrNkXZ7tSt-pLBCuEvA&amp;url=http://blog.zap2it.com/pop2it/2012/02/paula-deens-diabetes-drug-should-celebrities-be-endorsing-pharmaceuticals.html" alt = "" border = "1" width = "80" height = "80" /> <br /> <font size = "-2"> Zap2it.com (blog) </font> </a> </font> </td >
<td valign="top" class="j"> <font style = "font-size: 85 %; font-family: Arial, sans-serif "> <br /> 
<div style = "padding-top: 0.8em "> <img alt="" height="1" width="1" /> </div>
<p> class=&#8221;lh&#8221;> <a loss is the key in the fight against type 2 diabetes <b <> </b> / b> </a> <br /> <font size="-1" color="#6f6f6f"> San Francisco Chronicle </font> </b> </font> <br /> <font size="-1"> Q: I have been diagnosed with type 2 diabetes </b> and I am very confused insulin resistance, and what I can and carbohydrates can not eat. So much of what I read is contradictory. A: The first line of defense against type 2 diabetes </b> is weight loss, <b> &#8230; </B> </font> <br /> <font size="-1"> <a <b> Diabetics </b> fiasco </a> <font size = "-1" color = "# 6f6f6f" > <nobr> Coeur d&#8217;Alene Press </nobr> </font> </font> <br /> <font size="-1"> <a Deen: poster child for type 2 diabetes </b> and sugar intake </a> <font size="-1" color="#6f6f6f"> <nobr> Blogcritics.org (blog) </nobr> </font> </font> <br /> <font size = "-1"> <a Deen <b> diabetes </b> drug: Should celebrities be in favor of pharmaceutical </a> <font size="-1" color="#6f6f6f"> <nobr> Zap2it.com (blog ) </nobr> </font> </font> <br /> <font size="-1" class="p"> <a Herald Leader </nobr> </a> &#8211; <a Journal Gazette </nobr> </a> &#8211; <a News </nobr> </a> </font> <br /> <font size="-1"> class = &#8220;p&#8221; <a class = "p" href = "http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNH6oFS_jeNnA2E0j9_ZiVmLpZ3iwA&amp;url=http://www.sfgate.com/cgi-bin/article.cgi?f%3D/c/a/2012/02/03/FD9Q1MUVST.DTL"> <nobr> <b> all 12 news article&#8221; </b> </nobr> </a> </font> </div>
<p> </font> </td>
</tr>
</table>
<p><A rel = "nofollow" - Google News </a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.santoforhall.com/2012/02/04/the-weight-loss-is-the-key-in-the-fight-against-type-2-diabetes-san-francisco-chronicle/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Distinguish Type 1 From Type 2 Diabetes in Obese Youth &#8211; Family Practice News Digital Network</title>
		<link>http://www.santoforhall.com/2012/02/03/distinguish-type-1-from-type-2-diabetes-in-obese-youth-family-practice-news-digital-network/</link>
		<comments>http://www.santoforhall.com/2012/02/03/distinguish-type-1-from-type-2-diabetes-in-obese-youth-family-practice-news-digital-network/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 22:00:08 +0000</pubDate>
		<dc:creator>Scott Lewis</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Digital]]></category>
		<category><![CDATA[Distinguish]]></category>
		<category><![CDATA[Family]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[Network]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Obese]]></category>
		<category><![CDATA[Practice]]></category>
		<category><![CDATA[Type]]></category>
		<category><![CDATA[youth]]></category>

		<guid isPermaLink="false">http://www.santoforhall.com/2012/02/03/distinguish-type-1-from-type-2-diabetes-in-obese-youth-family-practice-news-digital-network/</guid>
		<description><![CDATA[PR Web (press release) Distinguish Type 1 From Type 2 Diabetes in Obese YouthFamily Practice News Digital Network(EGMN) – New-onset type 1 diabetes in an obese youth cannot reliably be distinguished from pediatric type 2 diabetes on clinical grounds in this era of epidemic obesity. &#34;The only way to distinguish obese type 1 diabetes from [...]]]></description>
			<content:encoded><![CDATA[<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;">
<tr>
<td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial,sans-serif"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNHIm8v-PqxFVHkD6jqeVrHV3zUKIw&amp;url=http://www.prweb.com/releases/DiabetesPrevention2012/Program01/prweb9148130.htm"><img src="//nt0.ggpht.com/news/tbn/fIzUrV8-ZiaRuM/6.jpg" alt="" border="1" width="80" height="80" /><br /><font size="-2">PR Web (press release)</font></a></font></td>
<td valign="top" class="j"><font style="font-size:85%;font-family:arial,sans-serif">
<div style="padding-top:0.8em;"><img alt="" height="1" width="1" /></div>
<div class="lh"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNGSif-gMypKpu_IjlApsoP4ab5DOA&amp;url=http://www.familypracticenews.com/news/more-top-news/single-view/distinguish-type-1-from-type-2-diabetes-in-obese-youth/ab5b3b8571.html"><b>Distinguish Type 1 From Type 2 <b>Diabetes</b> in Obese Youth</b></a><br /><font size="-1"><b><font color="#6f6f6f">Family Practice News Digital Network</font></b></font><br /><font size="-1">(EGMN) – New-onset type 1 <b>diabetes</b> in an obese youth cannot reliably be distinguished from pediatric type 2 <b>diabetes</b> on clinical grounds in this era of epidemic obesity. &quot;The only way to distinguish obese type 1 <b>diabetes</b> from type 2 <b>diabetes</b> is to <b>&#8230;</b></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNE3dvkGCMYE7NJmG8K96mGi5bxSQw&amp;url=http://www.marketwatch.com/story/phoenix-diabetes-lifestyle-coach-and-endocrinologist-host-free-informative-event-for-families-2012-02-03">Phoenix <b>Diabetes</b> Lifestyle Coach and Endocrinologist Host Free, Informative <b>&#8230;</b></a><font size="-1" color="#6f6f6f"><nobr>MarketWatch (press release)</nobr></font></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNFnlcELqspIhNEtMFJ3V4_7kIu4dw&amp;url=http://www.echo-pilot.com/lifestyle/health/x458333465/Over-the-Counter-Live-healthier-now-and-later">Over the Counter: Live healthier now and later</a><font size="-1" color="#6f6f6f"><nobr>Echo Pilot</nobr></font></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNHIm8v-PqxFVHkD6jqeVrHV3zUKIw&amp;url=http://www.prweb.com/releases/DiabetesPrevention2012/Program01/prweb9148130.htm">According to Recent Studies 26 Million Americans are Living with <b>Diabetes</b> and <b>&#8230;</b></a><font size="-1" color="#6f6f6f"><nobr>PR Web (press release)</nobr></font></font><br /><font size="-1" class="p"></font><br /><font class="p" size="-1"><a class="p" href="http://news.google.com/news/more?ncl=diRzHloMaUWScdMNG45-U4KEj5RIM&amp;ned=us"><nobr><b>all 75 news articles&nbsp;&raquo;</b></nobr></a></font></div>
<p></font></td>
</tr>
</table>
<p><a rel="nofollow" href="http://news.google.com/news/url?sa=t&#038;fd=R&#038;usg=AFQjCNGSif-gMypKpu_IjlApsoP4ab5DOA&#038;url=http://www.familypracticenews.com/news/more-top-news/single-view/distinguish-type-1-from-type-2-diabetes-in-obese-youth/ab5b3b8571.html">diabetes &#8211; Google News</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.santoforhall.com/2012/02/03/distinguish-type-1-from-type-2-diabetes-in-obese-youth-family-practice-news-digital-network/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Okays Merck&#8217;s Janumet XR For Type 2 Diabetes &#8211; Update &#8211; RTT News</title>
		<link>http://www.santoforhall.com/2012/02/03/fda-okays-mercks-janumet-xr-for-type-2-diabetes-update-rtt-news/</link>
		<comments>http://www.santoforhall.com/2012/02/03/fda-okays-mercks-janumet-xr-for-type-2-diabetes-update-rtt-news/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 01:59:55 +0000</pubDate>
		<dc:creator>Scott Lewis</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Janumet]]></category>
		<category><![CDATA[Merck's]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Okays]]></category>
		<category><![CDATA[Type]]></category>
		<category><![CDATA[Update]]></category>

		<guid isPermaLink="false">http://www.santoforhall.com/2012/02/03/fda-okays-mercks-janumet-xr-for-type-2-diabetes-update-rtt-news/</guid>
		<description><![CDATA[FDA Okays Merck&#39;s Janumet XR For Type 2 Diabetes &#8211; UpdateRTT NewsInc. (MRK: News ) said Thursday the US Food and Drug Administration has approved its Janumet XR tablets as a new treatment for type 2 diabetes. The drug will be available in US pharmacies in the next several weeks. Janumet XR combines sitagliptin, &#8230;FDA [...]]]></description>
			<content:encoded><![CDATA[<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;">
<tr>
<td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial,sans-serif"></font></td>
<td valign="top" class="j"><font style="font-size:85%;font-family:arial,sans-serif">
<div style="padding-top:0.8em;"><img alt="" height="1" width="1" /></div>
<div class="lh"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEdRmbIvh8idqbCCSh7KFBrwo23Ag&amp;url=http://www.rttnews.com/1811850/FDA-Okays-Merck-s-Janumet-XR-For-Type-2-Diabetes-Update.aspx?type%3Dfdp%26utm_source%3Dgoogle%26utm_campaign%3Dsitemap"><b>FDA Okays Merck&#39;s Janumet XR For Type 2 <b>Diabetes</b> &#8211; Update</b></a><br /><font size="-1"><b><font color="#6f6f6f">RTT News</font></b></font><br /><font size="-1">Inc. (MRK: News ) said Thursday the US Food and Drug Administration has approved its Janumet XR tablets as a new treatment for type 2 <b>diabetes</b>. The drug will be available in US pharmacies in the next several weeks. Janumet XR combines sitagliptin, <b>&#8230;</b></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNFnDnzVVtPm5uCAxRBvYVTVCZZnVQ&amp;url=http://www.marketwatch.com/story/fda-approves-janumetr-xr-sitagliptin-and-metformin-hcl-extended-release-for-type-2-diabetes-offering-the-powerful-efficacy-of-janumetr-sitagliptinmetformin-hcl-now-available-with-once-daily-convenience-2012-02-02?reflink%3DMW_news_stmp">FDA Approves JANUMET(R) XR (sitagliptin and metformin HCl extended-release <b>&#8230;</b></a><font size="-1" color="#6f6f6f"><nobr>MarketWatch (press release)</nobr></font></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEiAwi-b47z79YQX225RWO2X9GnxQ&amp;url=http://www.boston.com/business/healthcare/articles/2012/02/02/merck_wins_approval_for_extended_release_janumet/">Merck wins approval for extended release Janumet</a><font size="-1" color="#6f6f6f"><nobr>Boston.com</nobr></font></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNHKOocTe6FOx3Xdramey6es9ejmRw&amp;url=http://eon.businesswire.com/news/eon/20120202006572/en">FDA Approves JANUMET® XR (sitagliptin and metformin HCl extended-release) for <b>&#8230;</b></a><font size="-1" color="#6f6f6f"><nobr>EON: Enhanced Online News (press release)</nobr></font></font><br /><font size="-1" class="p"></font><br /><font class="p" size="-1"><a class="p" href="http://news.google.com/news/more?ncl=dAzmR60Z2xt4S-M36GB5YOQnTBAZM&amp;ned=us"><nobr><b>all 24 news articles&nbsp;&raquo;</b></nobr></a></font></div>
<p></font></td>
</tr>
</table>
<p><a rel="nofollow" href="http://news.google.com/news/url?sa=t&#038;fd=R&#038;usg=AFQjCNEdRmbIvh8idqbCCSh7KFBrwo23Ag&#038;url=http://www.rttnews.com/1811850/FDA-Okays-Merck-s-Janumet-XR-For-Type-2-Diabetes-Update.aspx?type%3Dfdp%26utm_source%3Dgoogle%26utm_campaign%3Dsitemap">diabetes &#8211; Google News</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.santoforhall.com/2012/02/03/fda-okays-mercks-janumet-xr-for-type-2-diabetes-update-rtt-news/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Type 1 diabetes treatment study in disappointment &#8211; iVillage Entertainment</title>
		<link>http://www.santoforhall.com/2012/02/02/type-1-diabetes-treatment-study-in-disappointment-ivillage-entertainment/</link>
		<comments>http://www.santoforhall.com/2012/02/02/type-1-diabetes-treatment-study-in-disappointment-ivillage-entertainment/#comments</comments>
		<pubDate>Thu, 02 Feb 2012 09:41:12 +0000</pubDate>
		<dc:creator>Scott Lewis</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[disappointment]]></category>
		<category><![CDATA[Entertainment]]></category>
		<category><![CDATA[iVillage]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[Type]]></category>

		<guid isPermaLink="false">http://www.santoforhall.com/2012/02/02/type-1-diabetes-treatment-study-in-disappointment-ivillage-entertainment/</guid>
		<description><![CDATA[Family Practice News Digital Network style = class=&#8221;lh&#8221;> to handle the latest study with a drug called GAD-alum for type 1 diabetes]]></description>
			<content:encoded><![CDATA[<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;">
<td width="80" align="center" valign="top"> <font style = "font-size: 85%; font-family: Arial, sans-serif"> <a src = "//nt1.ggpht.com/news/tbn/BT_dPa7826Wt2M/6.jpg" alt = "" border = "1 "width =" 80 "height =" 80 "/> <br /> <font size = "-2"> Family Practice News Digital Network </font> </a> </font> </td>
<td valign = "top" class = "j"> style = <font "font-size: 85%; font-family: Arial, sans-serif "> <br /> 
<div style = "padding-top: 0.8em;" > <img alt="" height="1" width="1" /> </div>
<p> class=&#8221;lh&#8221;> <a 1 Apartments diabetes </b> Treatment disappointed in Study </b> </a> <br /> <font size="-1" color="#6f6f6f"> iVillage Entertainment </font> </b> </font> <br /> <font size = "-1"> 1 (HealthDay News) &#8211; were able> to handle the latest study with a drug called GAD-alum for type 1 diabetes </b no significant improvement in the common marker of blood sugar disease show. The researchers said, however, they felt there possible reasons <b> &#8230;</b> </font> <br /> <font size="-1"> <a change may influence the effectiveness of vaccination against <b> Diabetes </b> </a> <font size="-1" color="#6f6f6f"> <nobr> Medical Xpress </nobr> </font> </font> <br /> <font size = "-1"> <a Tx advantages Some type 1 diabetics </a> <font size="-1" color="#6f6f6f"> <nobr> MedPage Today </nobr> </font> </font> <br /> <font "-1"> size = <a antigen therapy fails to halt progression of type 1 diabetes </b> </a> <font size = "-1" color = "# 6f6f6f"> <nobr> Family Practice News Digital Network </nobr> </font> </font> <br /> <font size="-1" class="p"> <a lounge </nobr> </a> </font> <br /> <font size="-1"> <a class = "p" 12 news articles »</b> </nobr> </a> </font> </div>
<p> </font> </td>
</tr>
</table>
<p><A rel = "nofollow" - Google News </a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.santoforhall.com/2012/02/02/type-1-diabetes-treatment-study-in-disappointment-ivillage-entertainment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Combination Type 2 Diabetes Pill Gets FDA Nod &#8211; Medscape</title>
		<link>http://www.santoforhall.com/2012/02/01/combination-type-2-diabetes-pill-gets-fda-nod-medscape/</link>
		<comments>http://www.santoforhall.com/2012/02/01/combination-type-2-diabetes-pill-gets-fda-nod-medscape/#comments</comments>
		<pubDate>Wed, 01 Feb 2012 01:59:53 +0000</pubDate>
		<dc:creator>Scott Lewis</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Combination]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[gets]]></category>
		<category><![CDATA[Medscape]]></category>
		<category><![CDATA[Pill']]></category>
		<category><![CDATA[Type]]></category>

		<guid isPermaLink="false">http://www.santoforhall.com/2012/02/01/combination-type-2-diabetes-pill-gets-fda-nod-medscape/</guid>
		<description><![CDATA[Combination Type 2 Diabetes Pill Gets FDA NodMedscapeJanuary 31, 2012 — The US Food and Drug Administration (FDA) today approved a combination pill containing the dipeptidyl peptidase-4 inhibitor linagliptin and metformin hydrochloride for the treatment of adults with type 2 diabetes.CORRECT(1/30): FDA Approves Eli Lilly Diabetes Combo Drug JentaduetoWall Street JournalFDA Approves Linagliptin/Metformin Combo For [...]]]></description>
			<content:encoded><![CDATA[<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;">
<tr>
<td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial,sans-serif"></font></td>
<td valign="top" class="j"><font style="font-size:85%;font-family:arial,sans-serif">
<div style="padding-top:0.8em;"><img alt="" height="1" width="1" /></div>
<div class="lh"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNGor7oIzxCjqh79iklsAlUE9DW4zg&amp;url=http://www.medscape.com/viewarticle/757821"><b>Combination Type 2 <b>Diabetes</b> Pill Gets FDA Nod</b></a><br /><font size="-1"><b><font color="#6f6f6f">Medscape</font></b></font><br /><font size="-1">January 31, 2012 — The US Food and Drug Administration (FDA) today approved a combination pill containing the dipeptidyl peptidase-4 inhibitor linagliptin and metformin hydrochloride for the treatment of adults with type 2 <b>diabetes</b>.</font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEkSCBIv8VRvpRo04HI3rbLSyvG_w&amp;url=http://online.wsj.com/article/BT-CO-20120131-713727.html">CORRECT(1/30): FDA Approves Eli Lilly <b>Diabetes</b> Combo Drug Jentadueto</a><font size="-1" color="#6f6f6f"><nobr>Wall Street Journal</nobr></font></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNGhL1E3uumSg5pLG0gaYPro3Y7aig&amp;url=http://www.familypracticenews.com/news/more-top-news/single-view/fda-approves-linagliptinmetformin-combo-for-type-2-diabetes/7fa9727165.html">FDA Approves Linagliptin/Metformin Combo For Type 2 <b>Diabetes</b></a><font size="-1" color="#6f6f6f"><nobr>Family Practice News Digital Network</nobr></font></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNGGOAZ_g0An4Ix_y4PK57_scRXa0Q&amp;url=http://www.financialpost.com/markets/news/approves%2BJentadueto%2Blinagliptin%2Bmetformin%2Bhydrochloride%2Btablets/6078756/story.html">FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for <b>&#8230;</b></a><font size="-1" color="#6f6f6f"><nobr>Financial Post</nobr></font></font><br /><font size="-1" class="p"></font><br /><font class="p" size="-1"><a class="p" href="http://news.google.com/news/more?gl=us&amp;pz=1&amp;ned=us&amp;ncl=dIBmyFPle0CS79MVt77tWcmBRjP1M"><nobr><b>all 44 news articles&nbsp;&raquo;</b></nobr></a></font></div>
<p></font></td>
</tr>
</table>
<p><a rel="nofollow" href="http://news.google.com/news/url?sa=t&#038;fd=R&#038;usg=AFQjCNGor7oIzxCjqh79iklsAlUE9DW4zg&#038;url=http://www.medscape.com/viewarticle/757821">diabetes &#8211; Google News</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.santoforhall.com/2012/02/01/combination-type-2-diabetes-pill-gets-fda-nod-medscape/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Weekly shot gets FDA nod for Type 2 diabetes &#8211; CBS News</title>
		<link>http://www.santoforhall.com/2012/01/30/weekly-shot-gets-fda-nod-for-type-2-diabetes-cbs-news/</link>
		<comments>http://www.santoforhall.com/2012/01/30/weekly-shot-gets-fda-nod-for-type-2-diabetes-cbs-news/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 00:11:12 +0000</pubDate>
		<dc:creator>Scott Lewis</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[gets]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Shot]]></category>
		<category><![CDATA[Type]]></category>
		<category><![CDATA[Weekly]]></category>

		<guid isPermaLink="false">http://www.santoforhall.com/2012/01/30/weekly-shot-gets-fda-nod-for-type-2-diabetes-cbs-news/</guid>
		<description><![CDATA[LifeHealthPro Weekly shot gets FDA nod for Type 2 diabetesCBS NewsThe FDA has given its nod to Bydureon, making it the first weekly treatment for type 2 diabetes, according to drug&#39;s manufacturer. Given as a shot, Bydureon (pronounced by-DUR-ee-on) is the long-acting form of Byetta, a twice-daily injection.Amylin&#39;s long-delayed diabetes drug gets FDA nodElizabethton StarAmylin [...]]]></description>
			<content:encoded><![CDATA[<table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;">
<tr>
<td width="80" align="center" valign="top"><font style="font-size:85%;font-family:arial,sans-serif"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNGZiGaWvGZoJs6XP_I7Zqg8awwcAw&amp;url=http://www.lifehealthpro.com/2012/01/30/fda-oks-once-a-week-successor-to-injectable-diabet"><img src="//nt2.ggpht.com/news/tbn/inf_8cX_zz5_xM/6.jpg" alt="" border="1" width="80" height="80" /><br /><font size="-2">LifeHealthPro</font></a></font></td>
<td valign="top" class="j"><font style="font-size:85%;font-family:arial,sans-serif">
<div style="padding-top:0.8em;"><img alt="" height="1" width="1" /></div>
<div class="lh"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNGM3pGrtNdTr_Qo3Y2-75RZKQyPlQ&amp;url=http://www.cbsnews.com/8301-500368_162-57367809/weekly-shot-gets-fda-nod-for-type-2-diabetes/"><b>Weekly shot gets FDA nod for Type 2 <b>diabetes</b></b></a><br /><font size="-1"><b><font color="#6f6f6f">CBS News</font></b></font><br /><font size="-1">The FDA has given its nod to Bydureon, making it the first weekly treatment for type 2 <b>diabetes</b>, according to drug&#39;s manufacturer. Given as a shot, Bydureon (pronounced by-DUR-ee-on) is the long-acting form of Byetta, a twice-daily injection.</font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNFd2JrFGbE64t7huErI-lVqrmIjVQ&amp;url=http://www.starhq.com/2012/01/30/amylins-long-delayed-diabetes-drug-gets-fda-nod/">Amylin&#39;s long-delayed <b>diabetes</b> drug gets FDA nod</a><font size="-1" color="#6f6f6f"><nobr>Elizabethton Star</nobr></font></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNH2MLID3DRtddCHRPuz0FcNqFAmYQ&amp;url=http://www.minyanville.com/businessmarkets/articles/amylin-alkermes-bydureon-fda-diabetes-victoza/1/30/2012/id/39102">Amylin Shares Rise on <b>Diabetes</b> Drug Approval, Challenges Loom</a><font size="-1" color="#6f6f6f"><nobr>Minyanville.com</nobr></font></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNH2j-6-8uAGDL54OmALcRO9X2MHMQ&amp;url=http://www.endocrinetoday.com/view.aspx?rid%3D91853">FDA approves exenatide extended-release for injectable suspension in type 2 <b>&#8230;</b></a><font size="-1" color="#6f6f6f"><nobr>Endocrine Today</nobr></font></font><br /><font size="-1" class="p"><a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNEofT5TUluCwbipJrOXKiXvI8eteg&amp;url=http://www.empowher.com/diabetes-type-2/content/fda-approves-bydureon-type-2-diabetes-new-not-always-better"><nobr>EmpowHer</nobr></a>&nbsp;-<a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNGZiGaWvGZoJs6XP_I7Zqg8awwcAw&amp;url=http://www.lifehealthpro.com/2012/01/30/fda-oks-once-a-week-successor-to-injectable-diabet"><nobr>LifeHealthPro</nobr></a>&nbsp;-<a href="http://news.google.com/news/url?sa=t&amp;fd=R&amp;usg=AFQjCNHz6dPc_MXzBktRC1_UF0bqQA72yQ&amp;url=http://www.zacks.com/stock/news/68714/Third%2BTime%2BLucky%2Bfor%2BAmylin&#39;s%2BBydureon"><nobr>Zacks.com</nobr></a></font><br /><font class="p" size="-1"><a class="p" href="http://news.google.com/news/more?gl=us&amp;pz=1&amp;ned=us&amp;ncl=dYdJTgmB1hITWIMnNfnYWkmFqUEtM"><nobr><b>all 272 news articles&nbsp;&raquo;</b></nobr></a></font></div>
<p></font></td>
</tr>
</table>
<p><a rel="nofollow" href="http://news.google.com/news/url?sa=t&#038;fd=R&#038;usg=AFQjCNGM3pGrtNdTr_Qo3Y2-75RZKQyPlQ&#038;url=http://www.cbsnews.com/8301-500368_162-57367809/weekly-shot-gets-fda-nod-for-type-2-diabetes/">diabetes &#8211; Google News</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.santoforhall.com/2012/01/30/weekly-shot-gets-fda-nod-for-type-2-diabetes-cbs-news/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

